National Cancer Institute
U.S. National Institutes of Health |

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
About NCI
Conducting Clinical Trials

General Information

Data and Safety Monitoring

List a Trial in NCI's PDQ®

Becoming a Co-Investigator

Starting a New Clinical Trial

Data Collection and Reporting

Participants in Clinical Trials

NIH Clinical Research Network Inventory

Insurance Coverage

Online Training and Education

Bibliographic Databases

Page Options
View Entire Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
Data Collection and Reporting

Cancer Data Standards Repository (caDSR) for Common Data Elements
A repository of terms that medical providers may use to collect patient information for clinical trials or for cancer care. NCI hopes to facilitate uniform standards for cancer clinical trials and patient care by assembling and maintaining this information on-line for all interested caregivers.

Clinical Data Update System (CDUS)
Primary data reporting mechanism for all NCI-sponsored clinical trials.

Adverse Event Expedited Reporting System (AdEERS)
NCI's Web-based system for submitting expedited reports for serious and/or unexpected events forwarded to designated recipients and the NCI for all trials using NCI-sponsored investigational agents.

Common Toxicity Criteria and Common Terminology Criteria for Adverse Events
Resources for standard terminology used to name and to describe the severity (grade) of adverse events that occur in the treatment of cancer.

< Previous Section  |  Next Section >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health